Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-8

  Ngu, Jing H ^a,b   Wallace, Mary C ^c   Merriman, Tony R ^d   Gearry, Richard B ^a,b   Stedman, Catherine A M ^a,b   Roberts, Rebecca L ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

03:01; 04:01; ALT levels; CTLA4; FAS; HLA A1 B8 DR3; HLA DRB; Severe fibrosis

Indexed keywords

EID: 84887274711     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-355     Document Type: Article

References (40)

1. Agarwal K, Czaja AJ, Donaldson PT (2007) A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens 69:227-235.
2. Agarwal K, Czaja AJ, Jones DE, Donaldson PT (2000) Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatol 31:49-53.
3. Ahmed I, Tamouza R, Delord M, Krishnamoorthy R, Tzourio C, Mulot C, Nacfer M, Lambert JC, Beaune P, Laurent-Puig P, Loriot MA, Charron D, Elbaz A (2012) Association between Parkinson's disease and the HLA-DRB1 locus. Mov Disord 27:1104-1110.
4. Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA (2008) Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 48:140-147.
5. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Buschenfelde KH M z, Zeniya M et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929-938.
6. Bittencourt PL, Palacios SA, Cancado EL, Porta G, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC (2003) Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am J Gastroenterol 98:1616-1620.
7. Czaja AJ (2008) Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol 6:379-388.
8. Czaja AJ, Manns MP (1995) The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 90:1206-1211.
9. Czaja AJ, Manns MP (2010) Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 139:58-72, e54.
10. Czaja AJ, Souto EO, Bittencourt PL, Cancado EL, Porta G, Goldberg AC, Donaldson PT (2002) Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol 37:302-308.
11. Djilali-Saiah I, Ouellette P, Caillat-Zucman S, Debray D, Kohn JI, Alvarez F (2001) CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis. Hum Immunol 62:1356-1362.
12. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, McFarlane IG, Johnson PJ, Eddleston AL, Mowat AP et al (1994) Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19:609-615.
13. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R (1991) Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13:701-706.
14. Fainboim L, Marcos Y, Pando M, Capucchio M, Reyes GB, Galoppo C, Badia I, Remondino G, Ciocca M, Ramonet M et al (1994) Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype. Hum Immunol 41:146-150.
15. Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, Stoecker W, Zhong R (2005) Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 20:249-255.
16. Fan LY, Tu XQ, Cheng QB, Zhu Y, Feltens R, Pfeiffer T, Zhong RQ (2004) Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World Journal of Gastroenterology 10:3056-3059.
17. Fortes Mdel P, Machado IV, Gil G, Fernandez-Mestre M, Dagher L, Leon RV, Bianco NE, Tassinari P (2007) Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela. Liver Int 27:1409-1416.
18. Fox CK, Furtwaengler A, Nepomuceno RR, Martinez OM, Krams SM (2001) Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis. Liver 21:272-279.
19. Hiraide A, Imazeki F, Yokosuka O, Kanda T, Kojima H, Fukai K, Suzuki Y, Hata A, Saisho H (2005a) Fas polymorphisms influence susceptibility to autoimmune hepatitis. Am J Gastroenterol 100:1322-1329.
20. Hiraide A, Imazeki F, Yokosuka O, Kanda T, Kojima H, Fukai K, Suzuki Y, Hata A, Saisho H (2005b) Fas polymorphisms influence susceptibility to autoimmune hepatitis. American Journal of Gastroenterology 100:1322-1329.
21. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165:6606-6611.
22. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
23. Miyake Y, Ikeda F, Takaki A, Nouso K, Yamamoto K (2011) +49A/G polymorphism of cytotoxic T-lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: A meta-analysis. Hepatol Res 41:151-159.
24. Ngu JH, Bechly K, Chapman BA, Burt MJ, Barclay ML, Gearry RB, Stedman CA (2010) Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol 25:1681-1686.
25. Ngu JH, Gearry RB, Frampton CM, Stedman CA (2012) Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury. New Zealand Hepatology 55:522-529.
26. Ngu JH, Gearry RB, Frampton CM, Stedman CA (2013) Predictors of poor outcome in patients with autoimmune hepatitis: a population-based study. Hepatology 57:2399-2406.
27. Pando M, Larriba J, Fernandez GC, Fainboim H, Ciocca M, Ramonet M, Badia I, Daruich J, Findor J, Tanno H, Canero-Velasco C, Fainboim L (1999) Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 30:1374-1380.
28. Santos PS, Fust G, Prohaszka Z, Volz A, Horton R, Miretti M, Yu CY, Beck S, Uchanska-Ziegler B, Ziegler A (2008) Association of smoking behavior with an odorant receptor allele telomeric to the human major histocompatibility complex. Genet Test 12:481-486.
29. Schott E, Witt H, Pascu M, van Boemmel F, Weich V, Bergk A, Halangk J, Muller T, Puhl G, Wiedenmann B, Berg T (2007) Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Eur J Gastroenterol Hepatol 19:947-951.
30. Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, Mizuki N, Ando A, Tsuji K, Inoko H et al (1992) HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 103:1041-1047.
31. Shi YY, He L (2005) SHE sis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97-98.
32. Simkins HM, Merriman ME, Highton J, Chapman PT, O'Donnell JL, Jones PB, Gow PJ, McLean L, Pokorny V, Harrison AA, Merriman TR (2005) Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis Rheum 52:2222-2225.
33. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathieson PW, Kleta R (2011) Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 364:616-626.
34. Strettell MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, Williams R (1997) Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 112:2028-2035.
35. Sun T, Zhou Y, Li H, Han X, Shi Y, Wang L, Miao X, Tan W, Zhao D, Zhang X, Guo Y, Lin D (2005) FASL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med 202:967-974.
36. Tang J, Zhou C, Zhang ZJ, Zheng SS (2012) Association of polymorphisms in non-classic MHC genes with susceptibility to autoimmune hepatitis. Hepatobiliary Pancreat Dis Int 11:125-131.
37. Umemura T, Ota M, Hamano H, Katsuyama Y, Muraki T, Arakura N, Kawa S, Kiyosawa K (2008a) Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 103:588-594.
38. Umemura T, Ota M, Yoshizawa K, Katsuyama Y, Ichijo T, Tanaka E, Kiyosawa K (2008b) Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese. Hepatol Res 38:689-695.
39. Vazquez-Garcia MN, Alaez C, Olivo A, Debaz H, Perez-Luque E, Burguete A, Cano S, de la Rosa G, Bautista N, Hernandez A, Bandera J, Torres LF, Kershenobich D, Alvarez F, Gorodezky C (1998) MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol 28:985-990.
40. Vogel A, Strassburgx MP, Manns MP (2002) Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35:126-131.